Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.3M Sell
613,727
-152,614
-20% -$10.2M 0.2% 98
2026
Q1
$48.1M Buy
766,341
+92,649
+14% +$6.45M 0.29% 74
2025
Q4
$44.7M Buy
673,692
+168,752
+33% +$10.9M 0.27% 74
2025
Q3
$34M Buy
504,940
+393,477
+353% +$31.1M 0.18% 88
2025
Q2
$9.73M Sell
111,463
-96,335
-46% -$7.55M 0.06% 173
2025
Q1
$14.2M Buy
207,798
+131,195
+171% +$10.7M 0.1% 136
2024
Q4
$5.96M Buy
76,603
+43,688
+133% +$3.23M 0.04% 258
2024
Q3
$2.21M Sell
32,915
-56,662
-63% -$4.65M 0.01% 410
2024
Q2
$10.2M Buy
+89,577
New +$11.3M 0.06% 224
2023
Q4
Sell
-5,617
Closed -$524K 585
2023
Q3
$524K Sell
5,617
-32,946
-85% -$3.71M ﹤0.01% 484
2023
Q2
$4.96M Buy
38,563
+36,137
+1,490% +$4.37M 0.04% 259
2023
Q1
$282K Sell
2,426
-88,348
-97% -$9.89M ﹤0.01% 501
2022
Q4
$10.3M Buy
+90,774
New +$9.97M 0.1% 153
2022
Q1
Sell
-67,072
Closed -$9M 550
2021
Q4
$9M Buy
67,072
+27,768
+71% +$3.99M 0.08% 193
2021
Q3
$5.37M Buy
39,304
+712
+2% +$89.8K 0.07% 185
2021
Q2
$4.12M Buy
38,592
+13,120
+52% +$1.26M 0.07% 185
2021
Q1
$2.29M Sell
25,472
-4
-0% -$375 0.05% 226
2020
Q4
$2.35M Buy
25,476
+17,000
+201% +$1.52M 0.05% 211
2020
Q3
$874K Buy
8,476
+5,352
+171% +$559K 0.04% 213
2020
Q2
$317K Buy
+3,124
New +$279K 0.01% 216

Other funds holding DXCM

ING Group's DXCM Position: Q2 2026 in Review

ING Group reduced its DexCom (DXCM) stake by 20% in Q2 2026, selling an estimated $10.2M and leaving 613,727 shares worth $41.3M. The position accounts for 0.2% of the portfolio, ranked #98.

ING Group first reported a position in DXCM in Q2 2020 and has held it in 20 quarters since. The position peaked at $48.1M in Q1 2026. 966 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • ING Group held 613,727 shares of DexCom worth $41.3M as of Q2 2026.
  • ING Group sold 152,614 DexCom shares in Q2 2026, an estimated $10.2M.
  • DexCom made up 0.2% of ING Group's portfolio in Q2 2026, its #98 holding.
  • ING Group first reported a position in DexCom in Q2 2020 and has held it in 20 quarters since.
  • ING Group's DexCom position peaked at $48.1M in Q1 2026.
  • 966 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on ING Group's 13F filing for Q2 2026, filed 13 Aug 2026.